Home > Resources > Company Profiles > CVS Caremark Corporation

CVS Caremark Corporation (CVS)

Your Name

Your Email Address *
Send a copy to me

Recipient's Email Address *

Separate multiple email addresses (max 20) with commas.

Subject *

Message

0/1500

Email Confirmation

Thomas M. Ryan , CEO/Director/President/Chairman of the Board

www.cvs.com

Industry: Retail

OPEN

LAST

PREV CLOSE

CHANGE

VOLUME

Overview

News

People

Financials

Overview

The Company is a provider of prescriptions and related healthcare services in the United States. It operates two business segments: Retail Pharmacy and Pharmacy Services.

Portfolio Articles

Valentine's Day: Outsource It
How to have your assistant choose a gift that says “I bought this myself.”

Feb 08 2008
For the YouTuber in You
Two low-priced, point-and-shoot video cameras designed to keep things simple.
Nov 19 2007

See more news on this company

News Feeds

Sector Snap: Drugstore chains skid as market falls AP
Oct 06 2008
Pharmacy benefits managers fall on bailout passage AP
Oct 03 2008
Drugstores pare gains after House approves bailout AP
Oct 03 2008
CVS disputes investment group in Longs fight AP
Oct 03 2008
Longs Drugs shares rose in 3Q, but rivals slipped AP
Sep 30 2008
Express Scripts had strongest 3Q among PBM stocks AP
Sep 30 2008
Pharmacy benefits managers dip on bailout failure AP
Sep 29 2008
List of no-short stocks is expanding AP
Sep 25 2008
Walgreen says may take Longs bid to shareholders AP
Sep 22 2008
Walgreen says it will continue Longs buyout effort AP
Sep 17 2008

Portfolio Blogs

Ackman's Short Win on Longs
Aug 12 2008
The Redcoats Are Coming
Jul 18 2007

Press Releases

CVS Caremark Cites Numerous Inaccuracies in Antitrust Memo Submitted to Longs Board Oct-03-2008, 08:45AM EDT
CVS/pharmacy Releases Survey Results on Consumer Plans for Flu Season Oct-02-2008, 09:00AM EDT
CVS Caremark Encourages Customers to 'Know Your Medicine, Know Your Pharmacist' During American Pharmacists Month in October Oct-01-2008, 09:00AM EDT
Beacon Equity Issues Technical Trade Alerts on Drug Store Stocks: WAG, CVS, MHS, LDG, RAD, PMC Sep-30-2008, 09:20AM EDT
CVS Caremark Corporation Announces Quarterly Dividend Sep-24-2008, 01:52PM EDT

News From Around the Web

News

Police: Suspect Tried To Rob CVS (Daily News Record, Virginia)

Oct 07 2008
Should a pharmacist admit fault after a dispensing error? (Modern Medicine)

Oct 06 2008
Sector Snap: Drugstore chains skid as market falls (Businessweek)

Oct 06 2008
Orlando CVS Store Becomes 50th Pharmacy Robbed In 2008 (ABC 9 Orlando (WFTV))

Oct 06 2008
Profiles In Travel Management: CVS Fills Prescription For Caremark Travel Integration (Business Travel News)

Oct 06 2008
CVS Store Becomes 50th Pharmacy Robbed In 2008 (ABC 9 Orlando (WFTV))

Oct 06 2008
Real Estate Notes: Tower’s conversion to hotel will be challenging (BizJournals)

Oct 06 2008
Kybecca opens wine bar. (Free Lance-Star, Fredericksburg, VA)

Oct 05 2008
CVS Faults Review of Longs/Walgreen Deal (CNBC)

Oct 04 2008
Retailers Rally Behind Their 'Captive Brands' (Brandweek)

Oct 04 2008

Blogs

The Short Life of the Short-Selling Ban (Conglomerate)

Oct 06 2008

Employees

Number of Employees: 120,000

Revenue per Employee: $692,181

Top Executives

David B. Rickard, Executive VP/CFO/Chief Administrative Officer

Larry J. Merlo, Executive VP/President, Divisional

V. Michael Ferdinandi, Divisional Senior VP

Chris W. Bodine, Other Corporate Officer

Howard A. McLure, Executive VP/President, Divisional

Paula A. Price, Senior VP/Controller/Chief Accounting Officer

Jonathan C. Roberts, Other Executive Officer/Senior VP, Subsidiary

Douglas A. Sgarro, Other Executive Officer/Executive VP

David M. Denton, CPA, Chief Accounting Officer/Controller/Senior VP

Board of Directors

C. David Brown, II, Director

Terrence Murray, Director

Richard J. Swift, Director

Kristen E. Gibney Williams, Director

David W. Dorman, Director

C.A. Lance Piccolo, Director

Marian L. Heard, Director

Dr.William H. Joyce, Director

Sheli Z. Rosenberg, Director

Edwin M. Banks, Director

Jean-Pierre Millon, Director

Financials

Quarterly

Annual

Income Statement	08/2008	05/2008	02/2008	11/2007
Sales	16.46 Bil.	16.73 Bil.	17.21 Bil.	16 Bil.
Gross Operating Profit	4.68 Bil.	4.59 Bil.	4.73 Bil.	4.5 Bil.
Operating Income before D & A (EBITDA)	1.79 Bil.	1.67 Bil.	1.75 Bil.	1.57 Bil.
Total Income Before Interest Expenses (EBIT)	1.48 Bil.	1.38 Bil.	1.48 Bil.	1.28 Bil.
Total Net Income	774.8 Mil.	748.5 Mil.	815 Mil.	689.5 Mil.
Basic EPS, Total	0.54	0.52	0.56	0.47
Diluted EPS, Total	0.53	0.51	0.55	0.45

BALANCE STATEMENT	08/2008	05/2008	02/2008	11/2007
Cash and Equivalents	615.7 Mil.	818.2 Mil.	1.06 Bil.	727.1 Mil.
Total Assets	13.61 Bil.	13.91 Bil.	14.1 Bil.	13.74 Bil.
Total Liabilities	8.81 Bil.	9.78 Bil.	10.77 Bil.	9.08 Bil.
Total Capitalization	41.36 Bil.	40.5 Bil.	39.67 Bil.	41.18 Bil.

Cash Flow	08/2008	05/2008	02/2008	11/2007
Net Cash From Continuing Operations	1.39 Bil.	740.8 Mil.	3.23 Bil.	1.87 Bil.
Net Cash From Investing Activities	-862.7 Mil.	-346.8 Mil.	-3.08 Bil.	-3.05 Bil.
Net Cash From Financing Activities	-970.3 Mil.	-632.4 Mil.	377.9 Mil.	1.38 Bil.
Net Change in Cash & Cash Equivalents	-440.9 Mil.	-238.4 Mil.	525.9 Mil.	196.4 Mil.

Income Statement	2008	2007	2006	2005
Sales	59.12 Bil.	31.87 Bil.	27.1 Bil.	22.62 Bil.
Gross Operating Profit	17.2 Bil.	11.94 Bil.	9.9 Bil.	7.97 Bil.
Operating Income before D & A (EBITDA)	5.89 Bil.	3.17 Bil.	2.61 Bil.	1.89 Bil.
Total Income Before Interest Expenses (EBIT)	4.79 Bil.	2.46 Bil.	2.03 Bil.	1.45 Bil.
Total Net Income	2.64 Bil.	1.37 Bil.	1.22 Bil.	918.8 Mil.
Basic EPS, Total	1.97	1.65	1.49	1.14
Diluted EPS, Total	1.92	1.6	1.45	1.1

BALANCE STATEMENT	2008	2007	2006	2005
Cash and Equivalents	1.06 Bil.	530.7 Mil.	513.4 Mil.	392.3 Mil.
Total Assets	14.1 Bil.	10.39 Bil.	8.39 Bil.	7.92 Bil.
Total Liabilities	10.77 Bil.	7 Bil.	4.58 Bil.	4.86 Bil.
Total Capitalization	39.67 Bil.	12.79 Bil.	9.93 Bil.	8.91 Bil.

Cash Flow	2008	2007	2006	2005
Net Cash From Continuing Operations	3.23 Bil.	1.74 Bil.	1.61 Bil.	914.2 Mil.
Net Cash From Investing Activities	-3.08 Bil.	-4.59 Bil.	-911.6 Mil.	-3.16 Bil.
Net Cash From Financing Activities	377.9 Mil.	2.87 Bil.	-579.4 Mil.	1.8 Bil.
Net Change in Cash & Cash Equivalents	525.9 Mil.	17.3 Mil.	121.1 Mil.	-450.9 Mil.

CVS Caremark Corporation (CVS)

Company Information

Overview

Employees

Top Executives

Board of Directors

Financials

Company Profile Change Request